semaglutide patients are shown in Table 3
Nine generic applications under Health Canada review Health Canada has confirmed that nine generic semaglutide medications are currently under review for approval in Canada, with the agency stating it is on track to meet its 180-day initial review target for those submissions
These nutrients help the body recycle and use glutathione more efficiently
In March 2025, Novo Nordisk launched NovoCare Pharmacy to provide direct-to-patient, convenient home shipments of all dose strengths of Wegovy at a reduced cost of $499 per month for self-paying patients
"It can make it even harder to try and stick to healthy eating and avoiding those foods that we know aren't good for us." But the new GLP-1 injectable drugs can turn down the volume, allowing those battling obesity to change their relationship with food
10.1016/0026-0495(92)90061-E Ishikura H, Matsuo N, Matsubara M, Ishihara T, Takeyama N, Tanaka T: Valproic acid overdose and L-carnitine therapy